Vivesto AB (LON: 0N4A)
London
· Delayed Price · Currency is GBP · Price in SEK
0.264
-0.004 (-1.31%)
Jan 16, 2025, 2:20 PM BST
Vivesto AB Revenue
Vivesto AB had revenue of 6.61M SEK in the twelve months ending September 30, 2024, up 226.52% year-over-year. In the year 2023, Vivesto AB had annual revenue of 6.61M with 117.50% growth.
Revenue
6.61M SEK
Revenue Growth
+226.52%
P/S Ratio
n/a
Revenue / Employee
472.29K SEK
Employees
14
Market Cap
9.20M GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 6.61M | 3.57M | 117.50% |
Dec 31, 2022 | 3.04M | -25.83M | -89.47% |
Dec 31, 2021 | 28.87M | 24.90M | 626.79% |
Dec 31, 2020 | 3.97M | -202.23M | -98.07% |
Apr 30, 2020 | 206.20M | 195.79M | 1,880.59% |
Apr 30, 2019 | Pro | Pro | Pro |
Apr 30, 2018 | Pro | Pro | Pro |
Apr 30, 2017 | Pro | Pro | Pro |
Apr 30, 2016 | Pro | Pro | Pro |
Apr 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |